S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

MNPR Monopar Therapeutics Inc

0.63

-0.005 (-0.79%)

Last Updated: 13:11:42

Delayed by 15 minutes

Form ARS - Annual Report to Security Holders

Monopar Therapeutics (NASDAQ:MNPR)
Historical Stock Chart
From Jun 2024 to Jul 2024

Click Here for more Monopar Therapeutics Charts.

Monopar Therapeutics (NASDAQ:MNPR)
Historical Stock Chart
From Jul 2023 to Jul 2024

Click Here for more Monopar Therapeutics Charts.

Monopar Therapeutics Inc News

Form ARS - Annual Report to Security Holders
Monday 22 July 2024 (1 day ago) • Edgar (US Regulatory)

Form DEF 14A - Other definitive proxy statements
Monday 22 July 2024 (1 day ago) • Edgar (US Regulatory)

Form PRE 14A - Other preliminary proxy statements
Thursday 11 July 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 9 July 2024 (2 weeks ago) • Edgar (US Regulatory)

Monopar Announces First Patient Enrolled in First-in-Human Phase 1 Trial for Its Novel Radiopharmaceutical MNPR-101-Zr
Tuesday 9 July 2024 (2 weeks ago) • GlobeNewswire Inc.

Monopar Announces MNPR-101-RIT Abstract Accepted as a Top-Rated Oral Presentation at EANM’24
Tuesday 25 June 2024 (4 weeks ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Monday 17 June 2024 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 11 June 2024 (1 month ago) • Edgar (US Regulatory)

Monopar and NorthStar Amend & Extend Collaboration
Tuesday 11 June 2024 (1 month ago) • GlobeNewswire Inc.

Form 8-K - Current report
Monday 10 June 2024 (1 month ago) • Edgar (US Regulatory)

Monopar Presents Data Showcasing the Appeal of uPAR as a Radiopharma Cancer Target and of its lead Clinical Program at the 2024 SNMMI Annual Meeting
Monday 10 June 2024 (1 month ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 5 June 2024 (2 months ago) • Edgar (US Regulatory)

More Monopar Therapeutics Inc News Articles

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions